Submitted by Anonymous (not verified) on 18 September 2023 - 13:45
Opinion/decision on a Paediatric investigation plan (PIP): Imfinzi,durvalumab, decision type: , therapeutic area: , PIP number: P/0366/2022
Source:
Opinion/decision on a Paediatric investigation plan (PIP): Imfinzi,durvalumab, decision type: , therapeutic area: , PIP number: P/0366/2022